| Previous Close | 25.33 |
| Open | 25.38 |
| Bid | 25.15 x 900 |
| Ask | 27.25 x 800 |
| Day's Range | 24.72 - 25.52 |
| 52 Week Range | 24.39 - 42.95 |
| Volume | 147,761 |
| Avg. Volume | 434,654 |
| Market Cap | 787.094M |
| Beta (3Y Monthly) | 0.40 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.90 |
| Earnings Date | Jul 30, 2019 - Aug 5, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 32.43 |
NEW YORK, NY / ACCESSWIRE / May 24, 2019 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Intersect ENT, Inc. ("Intersect" or the "Company")(XENT) of the July 15, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.
NEW YORK, NY / ACCESSWIRE / May 24, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment.
LOS ANGELES, CA / ACCESSWIRE / May 24, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Intersect ENT, Inc. ("Intersect" or "the Company") (XENT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between August 1, 2018 and May 6, 2019, inclusive (the "Class Period"), are encouraged to contact the firm before July 15, 2019.
NEW YORK, NY / ACCESSWIRE / May 24, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested ...
Shareholder rights law firm Robbins Arroyo LLP announces that a purchaser of Intersect ENT, Inc. (XENT) filed a class action complaint for alleged violations of the Securities Exchange Act of 1934 between August 1, 2018 and May 6, 2019. Intersect ENT's PROPEL family of products are used in conjunction with sinus surgery, and its SINUVA sinus implant is used to treat patients who have had surgery yet suffer from recurrent sinus obstruction due to polyps. According to the complaint, in August 2018, Intersect ENT revealed that it was facing challenges with the launch of SINUVA, which negatively impacted its second quarter 2018 financial results.
NEW YORK, May 24, 2019 -- The Law Offices of Vincent Wong remind investors that class actions have commenced on behalf of shareholders of the following companies. If you.
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announced that approximately seven weeks remain to make a motion to serve as a lead plaintiff in a class action pending against Intersect ENT, Inc. (“Intersect ENT,” “XENT” or the “Company”) (XENT) on behalf of those who purchased XENT securities between August 1, 2018 and May 6, 2019, both dates inclusive (the “Class Period”). If you purchased XENT securities during the Class Period, and/or would like to discuss your legal rights and options, please visit Intersect ENT Class Action Lawsuit or contact Matthew Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.
NEW YORK, NY / ACCESSWIRE / May 23, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have ...
LOS ANGELES, CA / ACCESSWIRE / May 23, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Intersect ENT, Inc. ("Intersect" or "the Company") (XENT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between August 1, 2018 and May 6, 2019, inclusive (the "Class Period"), are encouraged to contact the firm before July 15, 2019.
Law Offices of Howard G. Smith reminds investors of the upcoming July 15, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Intersect ENT, Inc. (“Intersect ENT” or the “Company”) (NASDAQ: XENT) securities between August 1, 2018 and May 6, 2019, inclusive (the “Class Period”). Investors suffering losses on their Intersect ENT investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com. On August 1, 2018, the Company disclosed that it faced certain challenges with the launch of INUVA, which had negatively impacted the Company’s second quarter 2018 financial results.
NEW YORK, NY / ACCESSWIRE / May 23, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have ...
Rosen Law Firm, a global investor rights law firm, reminds Intersect ENT, Inc. from August 1, 2018 through May 6, 2019, inclusive of the important July 15, 2019 lead plaintiff deadline in the securities class action.
NEW YORK, May 23, 2019 -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss.
NEW YORK, May 23, 2019 -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of American Renal.
NEW YORK, NY / ACCESSWIRE / May 22, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested ...
CEDARHURST, NY / ACCESSWIRE / May 22, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders ...
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming July 15, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of Intersect ENT, Inc. (“Intersect ENT” or the “Company”) (NASDAQ: XENT) investors who purchased securities between August 1, 2018 and May 6, 2019, inclusive (the “Class Period”). If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. On August 1, 2018, the Company disclosed that it faced certain challenges with the launch of INUVA, which had negatively impacted the Company’s second quarter 2018 financial results.
NEW YORK, NY / ACCESSWIRE / May 22, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have ...
NEW YORK, NY / ACCESSWIRE / May 22, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review ...
NEW YORK, NY / ACCESSWIRE / May 21, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have ...
Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed against Intersect ENT, Inc. (“Intersect ENT” or the “Company”) (XENT) in the United States District Court for the Northern District of California on behalf of those who purchased or acquired the securities of Intersect ENT between August 1, 2018 through May 6, 2019, inclusive (the “Class Period”).